The Basics
What is Encorafenib?
A drug for the treatment of certain melanomas.
Brand names for Encorafenib
N/A
How Encorafenib is classified
Antineoplastic Agents, Enzyme Inhibitors, Protein Kinase Inhibitors, Signal Transduction Inhibitors
Encorafenib During Pregnancy
Encorafenib pregnancy category
Category N/ANote that the FDA has deprecated the use of pregnancy categories, so for some medications, this information isn’t available. We still think it’s useful to list historical info, however, given what a common proxy this has been in the past.
What we know about taking Encorafenib while pregnant
N/A
Taking Encorafenib While Breastfeeding
What are recommendations for lactation if you're taking Encorafenib?
No information is available on the clinical use of encorafenib during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during encorafenib therapy and for at least 2 weeks after the final dose.
Maternal / infant drug levels
No information is available on the clinical use of encorafenib during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during encorafenib therapy and for at least 2 weeks after the final dose.
Possible effects of Encorafenib on milk supply
Relevant published information was not found as of the revision date.
Possible alternatives to Encorafenib
None listed
List of References
Lactation sources: Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK501922/None listed
Disclaimer: This material is provided for educational purposes only and is not intended for medical advice, diagnosis, or treatment. Consult your healthcare provider with any questions.
